DAG1 and muscular dystrophy-dystroglycanopathy, type A: Notably, a complete loss of α-dystroglycan glycosylation was found in cells from WWS patients, whereas the extent of α-dystroglycan glycosylation in cells from LGMDR9 patients was like that found in the control cells [213,214,215,216].